Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial.
作者:
主题词
女(雌)性(Female);人类(Humans);婴儿, 新生(Infant, Newborn);妊娠(Pregnancy);生物制品(Biological Products);炎性肠疾病(Inflammatory Bowel Diseases);坏死(Necrosis);妊娠结局(Pregnancy Outcome);复发(Recurrence);危险性评估(Risk Assessment);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.7326/M22-0819
PMID
36162111
发布时间
2023-05-23
- 浏览0

Annals of internal medicine
1374-1382页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文